Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on consecutive days [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million related to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the class action case, which is pending in the U.S. District Court for the Central District of California [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. due to allegations of violations of federal securities laws, particularly concerning misleading statements about the company's Long Island City property and its leasing value [4][6]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses in Alexandria between January 27, 2025, and October 27, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Alexandria, with a deadline of January 26, 2026, for investors to seek the role of lead plaintiff [4][8]. - The complaint alleges that Alexandria and its executives made false and misleading statements while concealing material adverse facts about the company's property [6]. Group 2: Financial Performance - Alexandria reported third-quarter earnings on October 27, 2025, which fell short of analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [7]. - The average occupancy rate for Alexandria declined from 94.8% in the previous year to 91.4% [7]. - Following the disappointing financial results, Alexandria's stock price dropped over 19% on October 28, 2025 [7].

Group 1 - The life science property sector is currently oversupplied, leading to challenges for companies in this space [1] - Alexandria Real Estate (ARE) has recently cut its dividend, indicating potential financial difficulties [1] - High-Yield Landlord is offering new members a promotional discount of $100 and a 30-day money-back guarantee to attract investors [1] Group 2 - Jussi Askola is the President of Leonberg Capital, specializing in REIT investing and has established relationships with top REIT executives [2] - High Yield Landlord provides features such as multiple portfolios, buy/sell alerts, and direct access to analysts for real-time investment insights [2]

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://w ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Alexandria Real Estate Equities, Inc. during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][3]. Group 1: Class Action Details - Investors who purchased Alexandria Real Estate securities between January 27, 2025, and October 27, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 26, 2026 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Background - The lawsuit alleges that defendants provided misleading information regarding Alexandria Real Estate's expected revenue and funds from operations growth for the 2025 fiscal year, particularly concerning its real estate operations [5]. - Defendants reportedly made positive statements about Alexandria Real Estate's lease activity and occupancy stability while concealing adverse facts about the true state of its Long Island City property, leading to investor damages when the truth emerged [6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Central District of California, captioned Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. - Investors have until January 26, 2026, to request to be appointed to lead the case [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on October 27-28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for alleged securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The lawsuit involves allegations against Alexandria and certain officers and/or directors regarding securities fraud [2]. - Investors have until January 26, 2026, to request to be appointed as Lead Plaintiff if they purchased Alexandria securities during the Class Period [2]. Group 2: Financial Performance - On October 27, 2025, Alexandria reported disappointing financial results for Q3 2025, including a reduction in full-year 2025 funds from operations (FFO) guidance [4]. - The company cited lower occupancy rates, slower leasing activity, and a significant real estate impairment charge of $323.9 million, with $206 million related to its Long Island City property [4]. Group 3: Market Reaction - Following the announcement of the financial results, Alexandria's stock price dropped by $14.93 per share, or 19.17%, closing at $62.94 per share on October 28, 2025 [5].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for allegedly making materially false and misleading statements regarding the company's Long Island City property and its leasing value as a life-science destination during the specified Class Period from January 27, 2025, to October 27, 2025 [3][7]. Allegation Details - The lawsuit claims that the defendants provided overwhelmingly positive statements while concealing adverse facts about the true state of the Long Island City property [3]. - It is alleged that the company's claims regarding the leasing value of the LIC property were misleading and lacked a reasonable basis, particularly concerning the Megacampus™ strategy [3]. - As a result, the defendants' statements about the company's business, operations, and prospects were materially false and misleading throughout the Class Period [3]. Next Steps for Investors - Investors who purchased or acquired Alexandria shares and suffered losses are encouraged to contact the law firm for more information about their rights and potential claims [4][7]. - There is no cost or obligation for investors to inquire about their legal options [4]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in various types of litigation, including securities and commercial litigation [5]. - The firm operates nationwide and handles cases in both federal and state courts [5].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - The company reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on consecutive days [6]. - Alexandria Real Estate announced a real estate impairment charge of $323.9 million, with $206 million related to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to seek appointment as lead plaintiffs in the case, which is pending in the U.S. District Court for the Central District of California [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Alexandria Real Estate is a real estate investment trust (REIT) focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Financial Performance - Alexandria Real Estate reported disappointing results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 on consecutive days [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. Legal Proceedings - Investors have until January 26, 2026, to request to lead the case in the U.S. District Court for the Central District of California, under the caption Hern v. Alexandria Real Estate Equities, Inc., et al. [3]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Alexandria Real Estate securities [3].